NO20044815L - Behandling av gastroparese - Google Patents
Behandling av gastropareseInfo
- Publication number
- NO20044815L NO20044815L NO20044815A NO20044815A NO20044815L NO 20044815 L NO20044815 L NO 20044815L NO 20044815 A NO20044815 A NO 20044815A NO 20044815 A NO20044815 A NO 20044815A NO 20044815 L NO20044815 L NO 20044815L
- Authority
- NO
- Norway
- Prior art keywords
- gastroparesis
- treatment
- glp
- patients
- compounds
- Prior art date
Links
- 206010021518 Impaired gastric emptying Diseases 0.000 title abstract 3
- 208000001288 gastroparesis Diseases 0.000 title abstract 3
- 230000030136 gastric emptying Effects 0.000 abstract 2
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 1
- 101001032756 Rattus norvegicus Granzyme-like protein 1 Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37165002P | 2002-04-10 | 2002-04-10 | |
| PCT/US2003/008457 WO2003087139A2 (en) | 2002-04-10 | 2003-03-27 | Treatment of gastroparesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044815L true NO20044815L (no) | 2005-01-07 |
Family
ID=29250714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044815A NO20044815L (no) | 2002-04-10 | 2004-11-05 | Behandling av gastroparese |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20050164925A1 (de) |
| EP (1) | EP1496924A4 (de) |
| JP (1) | JP2005530732A (de) |
| KR (1) | KR20040098063A (de) |
| CN (1) | CN1735423A (de) |
| AU (1) | AU2003220403A1 (de) |
| BR (1) | BR0308904A (de) |
| CA (1) | CA2480858A1 (de) |
| EA (1) | EA200401345A1 (de) |
| EC (1) | ECSP045345A (de) |
| HR (1) | HRP20040939A2 (de) |
| IL (1) | IL164266A0 (de) |
| MX (1) | MXPA04009929A (de) |
| NO (1) | NO20044815L (de) |
| NZ (1) | NZ535684A (de) |
| PL (1) | PL373658A1 (de) |
| WO (1) | WO2003087139A2 (de) |
| ZA (1) | ZA200408111B (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
| US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
| US8792985B2 (en) | 2003-07-21 | 2014-07-29 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
| TW200522976A (en) | 2003-09-19 | 2005-07-16 | Novo Nordisk As | Novel plasma protein affinity tags |
| EP2932981B1 (de) * | 2003-09-19 | 2021-06-16 | Novo Nordisk A/S | Albumin-bindende Derivative von GLP-1 |
| EP1793891B1 (de) | 2004-08-18 | 2011-11-09 | Metacure Limited | Überwachung, analyse und regulierung von essgewohnheiten |
| WO2006087712A2 (en) | 2005-02-17 | 2006-08-24 | Metacure N.V. | Charger with data transfer capabilities |
| US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
| JP5755398B2 (ja) | 2005-03-18 | 2015-07-29 | ノヴォ ノルディスク アー／エス | 伸長されたｇｌｐ−１化合物 |
| TWI362392B (en) | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| WO2007080595A2 (en) | 2006-01-12 | 2007-07-19 | Metacure N.V. | Electrode assemblies, tools, and methods for gastric wall implantation |
| WO2006102626A2 (en) * | 2005-03-24 | 2006-09-28 | Metacure Nv | Wireless leads for gastrointestinal tract applications |
| US8301256B2 (en) | 2005-06-02 | 2012-10-30 | Metacure Limited | GI lead implantation |
| US8442841B2 (en) * | 2005-10-20 | 2013-05-14 | Matacure N.V. | Patient selection method for assisting weight loss |
| US8295932B2 (en) | 2005-12-05 | 2012-10-23 | Metacure Limited | Ingestible capsule for appetite regulation |
| AU2012203915B9 (en) * | 2006-04-20 | 2014-10-09 | Amgen Inc. | GLP-1 compounds |
| EP2573111A1 (de) * | 2006-04-20 | 2013-03-27 | Amgen Inc. | GLP-1-Verbindungen |
| EP2150308B1 (de) * | 2007-05-09 | 2018-08-08 | MetaCure Limited | Analyse und regulierung der nahrungsaufnahme |
| US8423130B2 (en) * | 2008-05-09 | 2013-04-16 | Metacure Limited | Optimization of thresholds for eating detection |
| CN102112157B (zh) | 2008-08-06 | 2013-05-29 | 诺沃-诺迪斯克保健股份有限公司 | 具有延长的体内效能的缀合蛋白 |
| TWI504405B (zh) | 2009-01-22 | 2015-10-21 | Novo Nordisk Healthcare Ag | 穩定的生長激素化合物 |
| WO2011015649A1 (en) | 2009-08-06 | 2011-02-10 | Novo Nordisk Health Care Ag | Growth hormones with prolonged in-vivo efficacy |
| WO2011017554A2 (en) * | 2009-08-07 | 2011-02-10 | Mannkind Corporation | Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| BR112012018116B1 (pt) | 2010-01-22 | 2022-06-21 | Novo Nordisk Health Care Ag | Conjugados de hormônio do crescimento com eficácia in vivo prolongada |
| AU2011208620B2 (en) | 2010-01-22 | 2015-04-16 | Novo Nordisk Health Care Ag | Stable growth hormone compounds |
| US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
| US20130123460A1 (en) | 2010-04-30 | 2013-05-16 | Sanwa Kagaku Kenkyusho Co., Ltd. | Peptide for improving biostability of bioactive substance, and bioactive substance having improved biostability |
| UA116217C2 (uk) | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| WO2014096150A1 (en) | 2012-12-21 | 2014-06-26 | Sanofi | Dual glp1/gip or trigonal glp1/gip/glucagon agonists |
| WO2014166836A1 (en) | 2013-04-05 | 2014-10-16 | Novo Nordisk A/S | Growth hormone compound formulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6268343B1 (en) * | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| US5981488A (en) * | 1997-03-31 | 1999-11-09 | Eli Lillly And Company | Glucagon-like peptide-1 analogs |
| IL142707A0 (en) * | 2000-04-27 | 2002-03-10 | Pfizer Prod Inc | Methods of treating obesity using a neurotensin receptor ligand |
-
2003
- 2003-03-27 JP JP2003584094A patent/JP2005530732A/ja active Pending
- 2003-03-27 CA CA002480858A patent/CA2480858A1/en not_active Abandoned
- 2003-03-27 IL IL16426603A patent/IL164266A0/xx unknown
- 2003-03-27 AU AU2003220403A patent/AU2003220403A1/en not_active Abandoned
- 2003-03-27 EP EP03716707A patent/EP1496924A4/de not_active Withdrawn
- 2003-03-27 US US10/508,762 patent/US20050164925A1/en not_active Abandoned
- 2003-03-27 MX MXPA04009929A patent/MXPA04009929A/es not_active Application Discontinuation
- 2003-03-27 NZ NZ535684A patent/NZ535684A/xx unknown
- 2003-03-27 PL PL03373658A patent/PL373658A1/xx unknown
- 2003-03-27 WO PCT/US2003/008457 patent/WO2003087139A2/en not_active Application Discontinuation
- 2003-03-27 CN CNA038080079A patent/CN1735423A/zh active Pending
- 2003-03-27 BR BR0308904-5A patent/BR0308904A/pt not_active IP Right Cessation
- 2003-03-27 KR KR10-2004-7016025A patent/KR20040098063A/ko not_active Application Discontinuation
- 2003-03-27 EA EA200401345A patent/EA200401345A1/ru unknown
-
2004
- 2004-10-07 HR HRP20040939 patent/HRP20040939A2/hr not_active Application Discontinuation
- 2004-10-07 ZA ZA200408111A patent/ZA200408111B/xx unknown
- 2004-10-08 EC EC2004005345A patent/ECSP045345A/es unknown
- 2004-11-05 NO NO20044815A patent/NO20044815L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003087139A3 (en) | 2004-01-08 |
| EP1496924A2 (de) | 2005-01-19 |
| WO2003087139A2 (en) | 2003-10-23 |
| HRP20040939A2 (en) | 2004-12-31 |
| CA2480858A1 (en) | 2003-10-23 |
| ECSP045345A (es) | 2006-04-19 |
| KR20040098063A (ko) | 2004-11-18 |
| US20050164925A1 (en) | 2005-07-28 |
| PL373658A1 (en) | 2005-09-05 |
| ZA200408111B (en) | 2005-10-07 |
| EA200401345A1 (ru) | 2005-08-25 |
| JP2005530732A (ja) | 2005-10-13 |
| EP1496924A4 (de) | 2007-05-30 |
| NZ535684A (en) | 2006-03-31 |
| MXPA04009929A (es) | 2006-03-10 |
| IL164266A0 (en) | 2005-12-18 |
| BR0308904A (pt) | 2005-05-03 |
| CN1735423A (zh) | 2006-02-15 |
| AU2003220403A1 (en) | 2003-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20044815L (no) | Behandling av gastroparese | |
| NO20052796L (no) | Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese | |
| GEP20084499B (en) | USE OF INTERFERON-ß FOR TREATMENT OF RENAL FAILURE | |
| ZA200500323B (en) | Use of lkb kinase inhibitors for the treatment of pain. | |
| UA85597C2 (ru) | Четвертичные соли как антагонисты ccr2 | |
| IS8142A (is) | Læknislyf gagnleg til meðferðar á verkjum | |
| NO20084341L (no) | Anvendelse av DPP-IV inhibitorer | |
| NO20054371L (no) | Somatostatin-dopamin kimaere analoger | |
| NZ609280A (en) | Method for treatment of constipation-predominant irritable bowel syndrome | |
| NO20051103L (no) | Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer | |
| NO20071534L (no) | Behandling av inflammatoriske forstyrrelser og smerte | |
| PL1648513T3 (pl) | Zastosowanie przeciwciał z optymalizowaną adcc do leczenia pacjentów słabo odpowiadających na leczenie przeciwciałami | |
| ATE384058T1 (de) | Thiazolderivate | |
| NO20071378L (no) | Tiazolo-naftylsyrer. | |
| TW200631584A (en) | A medicament related to mirtazapine for the treatment of hot flush | |
| MXPA05001885A (es) | El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica. | |
| HK1061817A1 (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
| MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. | |
| DK1530462T3 (da) | 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens | |
| NO20074913L (no) | Enhetsdoseringsformer av temozolomid | |
| GEP20094699B (en) | THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING ß-INTERFERON | |
| GB0415181D0 (en) | Compounds for use in the treatment of infection | |
| AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
| MY140194A (en) | Novel fusidic acid derivatives | |
| PL372534A1 (en) | The treatment of pain with ifendropil |